Status:
COMPLETED
Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 1
Eligibility:
All Genders
Brief Summary
This study is conducted in Asia. The aim of this observational study is to collect efficacy and safety data in diabetic patients with acute hyperglycemia using NovoRapid™ FlexPen™ as per normal clinic...
Eligibility Criteria
Inclusion
- Patients with diabetes mellitus (according to product labelling)
Exclusion
- Hypoglycaemia
- Hypersensitivity to insulin aspart or to any of the excipients (according to product labelling)
Key Trial Info
Start Date :
June 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
373 Patients enrolled
Trial Details
Trial ID
NCT00675220
Start Date
June 1 2007
End Date
December 1 2007
Last Update
October 28 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Manila, Philippines, 1605